Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota
Identifieur interne : 000B75 ( Istex/Corpus ); précédent : 000B74; suivant : 000B76Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota
Auteurs : P. Ungprasert ; D. A. Wetter ; C. S. Crowson ; E. L. MattesonSource :
- Journal of the European Academy of Dermatology and Venereology [ 0926-9959 ] ; 2016-10.
Abstract
Background: The epidemiology of cutaneous sarcoidosis is not well‐characterized as only referral‐based studies are available. Objectives: To characterize the epidemiology of cutaneous sarcoidosis, with emphasis on annual incidence and clinical characteristics, from 1976 to 2013. Methods: Inception cohorts of patients with incident isolated cutaneous sarcoidosis and incident systemic sarcoidosis with cutaneous involvement in 1976–2013 in Olmsted County, Minnesota, United States were identified based on comprehensive individual medical record review. Inclusion in the isolated cutaneous sarcoidosis cohort required physician diagnosis and skin biopsy showing non‐necrotizing granuloma. Inclusion in the systemic sarcoidosis with cutaneous involvement cohort required presence of systemic sarcoidosis and cutaneous lesions. Presence of systemic sarcoidosis was determined by physician diagnosis supported by histopathology of non‐necrotizing granuloma, characteristic radiologic features of intrathoracic sarcoidosis and exclusion of other granulomatous diseases. Cutaneous lesions were defined as either sarcoidosis‐specific or non‐specific. Results: There were 62 cases with sarcoidosis‐specific cutaneous lesions (36 cases of sarcoidosis‐specific cutaneous lesions and 26 cases of isolated cutaneous sarcoidosis) which corresponded to an incidence of 1.9 per 100 000 population. The female to male ratio was 2.1 : 1. Plaques, papules and subcutaneous nodules were the most commonly observed cutaneous lesions. There was no significant difference in cutaneous presentation between those who had isolated skin disease and those who had skin disease in association with systemic sarcoidosis. Prognosis of cutaneous sarcoidosis was favourable, as over 90% of patients had a good response to either glucocorticoids, hydroxychloroquine or tetracycline antibiotics. This study has a significant limitation, in that the studied population was predominantly Caucasians who generally have a lower prevalence of skin disease. Conclusions: The incidence of sarcoidosis‐specific cutaneous lesions was about 1.9 per 100 000 population with female predominance. The cutaneous presentations were similar among those with and without systemic sarcoidosis.
Url:
DOI: 10.1111/jdv.13760
Links to Exploration step
ISTEX:ACCC5804FFBF78BC8890F975DBF09145DD0EA6BFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title><author><name sortKey="Ungprasert, P" sort="Ungprasert, P" uniqKey="Ungprasert P" first="P." last="Ungprasert">P. Ungprasert</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: P.Ungprasert@gmail.com</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: P.Ungprasert@gmail.com</mods:affiliation></affiliation></author><author><name sortKey="Wetter, D A" sort="Wetter, D A" uniqKey="Wetter D" first="D. A." last="Wetter">D. A. Wetter</name><affiliation><mods:affiliation>Department of Dermatology, Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation></author><author><name sortKey="Crowson, C S" sort="Crowson, C S" uniqKey="Crowson C" first="C. S." last="Crowson">C. S. Crowson</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation></author><author><name sortKey="Matteson, E L" sort="Matteson, E L" uniqKey="Matteson E" first="E. L." last="Matteson">E. L. Matteson</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:ACCC5804FFBF78BC8890F975DBF09145DD0EA6BF</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1111/jdv.13760</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-0LJ6ZCXM-M/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000B75</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B75</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title><author><name sortKey="Ungprasert, P" sort="Ungprasert, P" uniqKey="Ungprasert P" first="P." last="Ungprasert">P. Ungprasert</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: P.Ungprasert@gmail.com</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: P.Ungprasert@gmail.com</mods:affiliation></affiliation></author><author><name sortKey="Wetter, D A" sort="Wetter, D A" uniqKey="Wetter D" first="D. A." last="Wetter">D. A. Wetter</name><affiliation><mods:affiliation>Department of Dermatology, Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation></author><author><name sortKey="Crowson, C S" sort="Crowson, C S" uniqKey="Crowson C" first="C. S." last="Crowson">C. S. Crowson</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation></author><author><name sortKey="Matteson, E L" sort="Matteson, E L" uniqKey="Matteson E" first="E. L." last="Matteson">E. L. Matteson</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title><title level="j" type="alt">JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY</title><idno type="ISSN">0926-9959</idno><idno type="eISSN">1468-3083</idno><imprint><biblScope unit="vol">30</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1799">1799</biblScope><biblScope unit="page" to="1804">1804</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2016-10">2016-10</date></imprint><idno type="ISSN">0926-9959</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0926-9959</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Background: The epidemiology of cutaneous sarcoidosis is not well‐characterized as only referral‐based studies are available. Objectives: To characterize the epidemiology of cutaneous sarcoidosis, with emphasis on annual incidence and clinical characteristics, from 1976 to 2013. Methods: Inception cohorts of patients with incident isolated cutaneous sarcoidosis and incident systemic sarcoidosis with cutaneous involvement in 1976–2013 in Olmsted County, Minnesota, United States were identified based on comprehensive individual medical record review. Inclusion in the isolated cutaneous sarcoidosis cohort required physician diagnosis and skin biopsy showing non‐necrotizing granuloma. Inclusion in the systemic sarcoidosis with cutaneous involvement cohort required presence of systemic sarcoidosis and cutaneous lesions. Presence of systemic sarcoidosis was determined by physician diagnosis supported by histopathology of non‐necrotizing granuloma, characteristic radiologic features of intrathoracic sarcoidosis and exclusion of other granulomatous diseases. Cutaneous lesions were defined as either sarcoidosis‐specific or non‐specific. Results: There were 62 cases with sarcoidosis‐specific cutaneous lesions (36 cases of sarcoidosis‐specific cutaneous lesions and 26 cases of isolated cutaneous sarcoidosis) which corresponded to an incidence of 1.9 per 100 000 population. The female to male ratio was 2.1 : 1. Plaques, papules and subcutaneous nodules were the most commonly observed cutaneous lesions. There was no significant difference in cutaneous presentation between those who had isolated skin disease and those who had skin disease in association with systemic sarcoidosis. Prognosis of cutaneous sarcoidosis was favourable, as over 90% of patients had a good response to either glucocorticoids, hydroxychloroquine or tetracycline antibiotics. This study has a significant limitation, in that the studied population was predominantly Caucasians who generally have a lower prevalence of skin disease. Conclusions: The incidence of sarcoidosis‐specific cutaneous lesions was about 1.9 per 100 000 population with female predominance. The cutaneous presentations were similar among those with and without systemic sarcoidosis.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>P. Ungprasert</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, MN, Rochester, USA</json:string><json:string>E-mail: P.Ungprasert@gmail.com</json:string><json:string>E-mail: P.Ungprasert@gmail.com</json:string></affiliations></json:item><json:item><name>D.A. Wetter</name><affiliations><json:string>Department of Dermatology, Mayo Clinic College of Medicine, MN, Rochester, USA</json:string></affiliations></json:item><json:item><name>C.S. Crowson</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</json:string><json:string>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</json:string></affiliations></json:item><json:item><name>E.L. Matteson</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</json:string><json:string>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</json:string></affiliations></json:item></author><articleId><json:string>JDV13760</json:string></articleId><arkIstex>ark:/67375/WNG-0LJ6ZCXM-M</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>shortCommunication</json:string></originalGenre><abstract>Background: The epidemiology of cutaneous sarcoidosis is not well‐characterized as only referral‐based studies are available. Objectives: To characterize the epidemiology of cutaneous sarcoidosis, with emphasis on annual incidence and clinical characteristics, from 1976 to 2013. Methods: Inception cohorts of patients with incident isolated cutaneous sarcoidosis and incident systemic sarcoidosis with cutaneous involvement in 1976–2013 in Olmsted County, Minnesota, United States were identified based on comprehensive individual medical record review. Inclusion in the isolated cutaneous sarcoidosis cohort required physician diagnosis and skin biopsy showing non‐necrotizing granuloma. Inclusion in the systemic sarcoidosis with cutaneous involvement cohort required presence of systemic sarcoidosis and cutaneous lesions. Presence of systemic sarcoidosis was determined by physician diagnosis supported by histopathology of non‐necrotizing granuloma, characteristic radiologic features of intrathoracic sarcoidosis and exclusion of other granulomatous diseases. Cutaneous lesions were defined as either sarcoidosis‐specific or non‐specific. Results: There were 62 cases with sarcoidosis‐specific cutaneous lesions (36 cases of sarcoidosis‐specific cutaneous lesions and 26 cases of isolated cutaneous sarcoidosis) which corresponded to an incidence of 1.9 per 100 000 population. The female to male ratio was 2.1 : 1. Plaques, papules and subcutaneous nodules were the most commonly observed cutaneous lesions. There was no significant difference in cutaneous presentation between those who had isolated skin disease and those who had skin disease in association with systemic sarcoidosis. Prognosis of cutaneous sarcoidosis was favourable, as over 90% of patients had a good response to either glucocorticoids, hydroxychloroquine or tetracycline antibiotics. This study has a significant limitation, in that the studied population was predominantly Caucasians who generally have a lower prevalence of skin disease. Conclusions: The incidence of sarcoidosis‐specific cutaneous lesions was about 1.9 per 100 000 population with female predominance. The cutaneous presentations were similar among those with and without systemic sarcoidosis.</abstract><qualityIndicators><score>7.682</score><pdfWordCount>2682</pdfWordCount><pdfCharCount>18988</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>6</pdfPageCount><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><pdfWordsPerPage>447</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>290</abstractWordCount><abstractCharCount>2244</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title><genre><json:string>brief-communication</json:string></genre><host><title>Journal of the European Academy of Dermatology and Venereology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1468-3083</json:string></doi><issn><json:string>0926-9959</json:string></issn><eissn><json:string>1468-3083</json:string></eissn><publisherId><json:string>JDV</json:string></publisherId><volume>30</volume><issue>10</issue><pages><first>1799</first><last>1804</last><total>6</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Short Report</value></json:item><json:item><value>INFLAMMATORY SKIN DISEASES</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-0LJ6ZCXM-M</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - dermatology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - dermatology & venereal diseases</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Infectious Diseases</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Dermatology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2016</publicationDate><copyrightDate>2016</copyrightDate><doi><json:string>10.1111/jdv.13760</json:string></doi><id>ACCC5804FFBF78BC8890F975DBF09145DD0EA6BF</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0LJ6ZCXM-M/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0LJ6ZCXM-M/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-0LJ6ZCXM-M/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2016 European Academy of Dermatology and Venereology</licence></availability><date type="published" when="2016-10"></date></publicationStmt><notesStmt><note type="content-type" subtype="brief-communication" source="shortCommunication" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="brief-communication"><analytic><title level="a" type="main">Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">P.</forename><surname>Ungprasert</surname></persName><email>P.Ungprasert@gmail.com</email><affiliation><orgName type="division">Division of Rheumatology</orgName>
<orgName type="institution">Department of Internal Medicine Mayo Clinic College of Medicine</orgName>
<address><settlement>Rochester</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">D.A.</forename><surname>Wetter</surname></persName><affiliation><orgName type="division">Department of Dermatology</orgName>
<orgName type="institution">Mayo Clinic College of Medicine</orgName>
<address><settlement>Rochester</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">C.S.</forename><surname>Crowson</surname></persName><affiliation><orgName type="division">Division of Rheumatology</orgName>
<orgName type="institution">Department of Internal Medicine Mayo Clinic College of Medicine</orgName>
<address><settlement>Rochester</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation><affiliation><orgName type="division">Division of Biomedical Statistics and Informatics</orgName>
<orgName type="division">Department of Health Sciences Research</orgName>
<orgName type="institution">Mayo Clinic College of Medicine</orgName>
<address><settlement>Rochester</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">E.L.</forename><surname>Matteson</surname></persName><affiliation><orgName type="division">Division of Rheumatology</orgName>
<orgName type="institution">Department of Internal Medicine Mayo Clinic College of Medicine</orgName>
<address><settlement>Rochester</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation><affiliation><orgName type="division">Division of Epidemiology</orgName>
<orgName type="division">Department of Health Sciences Research</orgName>
<orgName type="institution">Mayo Clinic College of Medicine</orgName>
<address><settlement>Rochester</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><idno type="istex">ACCC5804FFBF78BC8890F975DBF09145DD0EA6BF</idno><idno type="ark">ark:/67375/WNG-0LJ6ZCXM-M</idno><idno type="DOI">10.1111/jdv.13760</idno><idno type="unit">JDV13760</idno><idno type="toTypesetVersion">file:JDV.JDV13760.pdf</idno></analytic><monogr><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title><title level="j" type="alt">JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY</title><idno type="pISSN">0926-9959</idno><idno type="eISSN">1468-3083</idno><idno type="book-DOI">10.1111/(ISSN)1468-3083</idno><idno type="book-part-DOI">10.1111/jdv.2016.30.issue-10</idno><idno type="product">JDV</idno><imprint><biblScope unit="vol">30</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1799">1799</biblScope><biblScope unit="page" to="1804">1804</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2016-10"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract style="main" xml:id="jdv13760-abs-0001"><head>Abstract</head><head>Background</head><p>The epidemiology of cutaneous sarcoidosis is not well‐characterized as only referral‐based studies are available.</p><head>Objectives</head><p>To characterize the epidemiology of cutaneous sarcoidosis, with emphasis on annual incidence and clinical characteristics, from 1976 to 2013.</p><head>Methods</head><p>Inception cohorts of patients with incident isolated cutaneous sarcoidosis and incident systemic sarcoidosis with cutaneous involvement in 1976–2013 in Olmsted County, Minnesota, United States were identified based on comprehensive individual medical record review. Inclusion in the isolated cutaneous sarcoidosis cohort required physician diagnosis and skin biopsy showing non‐necrotizing granuloma. Inclusion in the systemic sarcoidosis with cutaneous involvement cohort required presence of systemic sarcoidosis and cutaneous lesions. Presence of systemic sarcoidosis was determined by physician diagnosis supported by histopathology of non‐necrotizing granuloma, characteristic radiologic features of intrathoracic sarcoidosis and exclusion of other granulomatous diseases. Cutaneous lesions were defined as either sarcoidosis‐specific or non‐specific.</p><head>Results</head><p>There were 62 cases with sarcoidosis‐specific cutaneous lesions (36 cases of sarcoidosis‐specific cutaneous lesions and 26 cases of isolated cutaneous sarcoidosis) which corresponded to an incidence of 1.9 per 100 000 population. The female to male ratio was 2.1 : 1. Plaques, papules and subcutaneous nodules were the most commonly observed cutaneous lesions. There was no significant difference in cutaneous presentation between those who had isolated skin disease and those who had skin disease in association with systemic sarcoidosis. Prognosis of cutaneous sarcoidosis was favourable, as over 90% of patients had a good response to either glucocorticoids, hydroxychloroquine or tetracycline antibiotics. This study has a significant limitation, in that the studied population was predominantly Caucasians who generally have a lower prevalence of skin disease.</p><head>Conclusions</head><p>The incidence of sarcoidosis‐specific cutaneous lesions was about 1.9 per 100 000 population with female predominance. The cutaneous presentations were similar among those with and without systemic sarcoidosis.</p></abstract><textClass><keywords rend="articleCategory"><term>Short Report</term></keywords><keywords rend="tocHeading1"><term>INFLAMMATORY SKIN DISEASES</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0LJ6ZCXM-M/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="jdv13760" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1468-3083</doi><issn type="print">0926-9959</issn><issn type="electronic">1468-3083</issn><idGroup><id type="product" value="JDV"></id></idGroup><titleGroup><title sort="JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY" type="main">Journal of the European Academy of Dermatology and Venereology</title><title type="short">J Eur Acad Dermatol Venereol</title></titleGroup></publicationMeta><publicationMeta level="part" position="100"><doi origin="wiley">10.1111/jdv.2016.30.issue-10</doi><copyright ownership="thirdParty">Copyright © 2016 European Academy of Dermatology and Venereology</copyright><numberingGroup><numbering type="journalVolume" number="30">30</numbering><numbering type="journalIssue">10</numbering></numberingGroup><coverDate startDate="2016-10">October 2016</coverDate></publicationMeta><publicationMeta level="unit" position="250" status="forIssue" type="shortCommunication"><doi>10.1111/jdv.13760</doi><idGroup><id type="unit" value="JDV13760"></id></idGroup><countGroup><count number="6" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">Short Report</title><title type="tocHeading1">INFLAMMATORY SKIN DISEASES</title></titleGroup><copyright ownership="thirdParty">© 2016 European Academy of Dermatology and Venereology</copyright><eventGroup><event date="2015-12-30" type="manuscriptReceived"></event><event date="2016-04-01" type="manuscriptAccepted"></event><event agent="SPS" date="2016-05-04" type="xmlCreated"></event><event type="firstOnline" date="2016-06-21"></event><event type="publishedOnlineEarlyUnpaginated" date="2016-06-21"></event><event type="publishedOnlineFinalForm" date="2016-10-19"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:5.0.6 mode:FullText" date="2017-02-10"></event></eventGroup><numberingGroup><numbering type="pageFirst">1799</numbering><numbering type="pageLast">1804</numbering></numberingGroup><correspondenceTo>Correspondence: P. Ungprasert. E‐mails: <email>P.Ungprasert@gmail.com</email>; <email>Ungprasert.Patompong@mayo.edu</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JDV.JDV13760.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="2"></count><count type="wordTotal" number="3682"></count></countGroup><titleGroup><title type="main">Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title><title type="shortAuthors">Ungprasert <i>et al</i>.</title></titleGroup><creators><creator affiliationRef="#jdv13760-aff-0001" corresponding="yes" creatorRole="author" xml:id="jdv13760-cr-0001"><personName><givenNames>P.</givenNames> <familyName>Ungprasert</familyName></personName><contactDetails><email>P.Ungprasert@gmail.com</email></contactDetails></creator><creator affiliationRef="#jdv13760-aff-0002" creatorRole="author" xml:id="jdv13760-cr-0002"><personName><givenNames>D.A.</givenNames> <familyName>Wetter</familyName></personName></creator><creator affiliationRef="#jdv13760-aff-0001 #jdv13760-aff-0003" creatorRole="author" xml:id="jdv13760-cr-0003"><personName><givenNames>C.S.</givenNames> <familyName>Crowson</familyName></personName></creator><creator affiliationRef="#jdv13760-aff-0001 #jdv13760-aff-0004" creatorRole="author" xml:id="jdv13760-cr-0004"><personName><givenNames>E.L.</givenNames> <familyName>Matteson</familyName></personName></creator></creators><affiliationGroup><affiliation countryCode="US" type="organization" xml:id="jdv13760-aff-0001"><orgDiv>Division of Rheumatology</orgDiv> <orgName>Department of Internal Medicine Mayo Clinic College of Medicine</orgName> <address><city>Rochester</city> <countryPart>MN</countryPart> <country>USA</country></address></affiliation><affiliation countryCode="US" type="organization" xml:id="jdv13760-aff-0002"><orgDiv>Department of Dermatology</orgDiv> <orgName>Mayo Clinic College of Medicine</orgName> <address><city>Rochester</city> <countryPart>MN</countryPart> <country>USA</country></address></affiliation><affiliation countryCode="US" type="organization" xml:id="jdv13760-aff-0003"><orgDiv>Division of Biomedical Statistics and Informatics</orgDiv> <orgDiv>Department of Health Sciences Research</orgDiv> <orgName>Mayo Clinic College of Medicine</orgName> <address><city>Rochester</city> <countryPart>MN</countryPart> <country>USA</country></address></affiliation><affiliation countryCode="US" type="organization" xml:id="jdv13760-aff-0004"><orgDiv>Division of Epidemiology</orgDiv> <orgDiv>Department of Health Sciences Research</orgDiv> <orgName>Mayo Clinic College of Medicine</orgName> <address><city>Rochester</city> <countryPart>MN</countryPart> <country>USA</country></address></affiliation></affiliationGroup><fundingInfo><fundingAgency fundRefName="National Institute on Aging" funderDoi="10.13039/100000049">National Institute on Aging of the National Institutes of Health</fundingAgency><fundingNumber>R01 AG034676</fundingNumber></fundingInfo><fundingInfo><fundingAgency>CTSA</fundingAgency><fundingNumber>UL1 TR000135</fundingNumber></fundingInfo><abstractGroup><abstract type="main" xml:id="jdv13760-abs-0001"><title type="main">Abstract</title><section xml:id="jdv13760-sec-0001"><title type="main">Background</title><p>The epidemiology of cutaneous sarcoidosis is not well‐characterized as only referral‐based studies are available.</p></section><section xml:id="jdv13760-sec-0002"><title type="main">Objectives</title><p>To characterize the epidemiology of cutaneous sarcoidosis, with emphasis on annual incidence and clinical characteristics, from 1976 to 2013.</p></section><section xml:id="jdv13760-sec-0003"><title type="main">Methods</title><p>Inception cohorts of patients with incident isolated cutaneous sarcoidosis and incident systemic sarcoidosis with cutaneous involvement in 1976–2013 in Olmsted County, Minnesota, United States were identified based on comprehensive individual medical record review. Inclusion in the isolated cutaneous sarcoidosis cohort required physician diagnosis and skin biopsy showing non‐necrotizing granuloma. Inclusion in the systemic sarcoidosis with cutaneous involvement cohort required presence of systemic sarcoidosis and cutaneous lesions. Presence of systemic sarcoidosis was determined by physician diagnosis supported by histopathology of non‐necrotizing granuloma, characteristic radiologic features of intrathoracic sarcoidosis and exclusion of other granulomatous diseases. Cutaneous lesions were defined as either sarcoidosis‐specific or non‐specific.</p></section><section xml:id="jdv13760-sec-0004"><title type="main">Results</title><p>There were 62 cases with sarcoidosis‐specific cutaneous lesions (36 cases of sarcoidosis‐specific cutaneous lesions and 26 cases of isolated cutaneous sarcoidosis) which corresponded to an incidence of 1.9 per 100 000 population. The female to male ratio was 2.1 : 1. Plaques, papules and subcutaneous nodules were the most commonly observed cutaneous lesions. There was no significant difference in cutaneous presentation between those who had isolated skin disease and those who had skin disease in association with systemic sarcoidosis. Prognosis of cutaneous sarcoidosis was favourable, as over 90% of patients had a good response to either glucocorticoids, hydroxychloroquine or tetracycline antibiotics. This study has a significant limitation, in that the studied population was predominantly Caucasians who generally have a lower prevalence of skin disease.</p></section><section xml:id="jdv13760-sec-0005"><title type="main">Conclusions</title><p>The incidence of sarcoidosis‐specific cutaneous lesions was about 1.9 per 100 000 population with female predominance. The cutaneous presentations were similar among those with and without systemic sarcoidosis.</p></section></abstract></abstractGroup></contentMeta><noteGroup xml:id="jdv13760-ntgp-0001"><note numbered="no" xml:id="jdv13760-note-1001"><p><b>Conflicts of interest</b></p><p>We do not have any financial or non‐financial potential conflicts of interest.</p></note><note numbered="no" xml:id="jdv13760-note-1002"><p><b>Funding sources</b></p><p>This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01 AG034676, and CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences, NCATS, a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Ungprasert</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, MN, Rochester, USA</affiliation><affiliation>E-mail: P.Ungprasert@gmail.com</affiliation><affiliation>E-mail: P.Ungprasert@gmail.com</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.A.</namePart><namePart type="family">Wetter</namePart><affiliation>Department of Dermatology, Mayo Clinic College of Medicine, MN, Rochester, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.S.</namePart><namePart type="family">Crowson</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</affiliation><affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.L.</namePart><namePart type="family">Matteson</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine Mayo Clinic College of Medicine, Rochester, MN, USA</affiliation><affiliation>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, MN, Rochester, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief-communication" displayLabel="shortCommunication" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2016-10</dateIssued><dateCreated encoding="w3cdtf">2016-05-04</dateCreated><dateCaptured encoding="w3cdtf">2015-12-30</dateCaptured><dateValid encoding="w3cdtf">2016-04-01</dateValid><copyrightDate encoding="w3cdtf">2016</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">2</extent><extent unit="tables">2</extent><extent unit="words">3682</extent></physicalDescription><abstract>Background: The epidemiology of cutaneous sarcoidosis is not well‐characterized as only referral‐based studies are available. Objectives: To characterize the epidemiology of cutaneous sarcoidosis, with emphasis on annual incidence and clinical characteristics, from 1976 to 2013. Methods: Inception cohorts of patients with incident isolated cutaneous sarcoidosis and incident systemic sarcoidosis with cutaneous involvement in 1976–2013 in Olmsted County, Minnesota, United States were identified based on comprehensive individual medical record review. Inclusion in the isolated cutaneous sarcoidosis cohort required physician diagnosis and skin biopsy showing non‐necrotizing granuloma. Inclusion in the systemic sarcoidosis with cutaneous involvement cohort required presence of systemic sarcoidosis and cutaneous lesions. Presence of systemic sarcoidosis was determined by physician diagnosis supported by histopathology of non‐necrotizing granuloma, characteristic radiologic features of intrathoracic sarcoidosis and exclusion of other granulomatous diseases. Cutaneous lesions were defined as either sarcoidosis‐specific or non‐specific. Results: There were 62 cases with sarcoidosis‐specific cutaneous lesions (36 cases of sarcoidosis‐specific cutaneous lesions and 26 cases of isolated cutaneous sarcoidosis) which corresponded to an incidence of 1.9 per 100 000 population. The female to male ratio was 2.1 : 1. Plaques, papules and subcutaneous nodules were the most commonly observed cutaneous lesions. There was no significant difference in cutaneous presentation between those who had isolated skin disease and those who had skin disease in association with systemic sarcoidosis. Prognosis of cutaneous sarcoidosis was favourable, as over 90% of patients had a good response to either glucocorticoids, hydroxychloroquine or tetracycline antibiotics. This study has a significant limitation, in that the studied population was predominantly Caucasians who generally have a lower prevalence of skin disease. Conclusions: The incidence of sarcoidosis‐specific cutaneous lesions was about 1.9 per 100 000 population with female predominance. The cutaneous presentations were similar among those with and without systemic sarcoidosis.</abstract><note type="funding">National Institute on Aging of the National Institutes of Health - No. R01 AG034676; </note><note type="funding">CTSA - No. UL1 TR000135; </note><relatedItem type="host"><titleInfo><title>Journal of the European Academy of Dermatology and Venereology</title></titleInfo><titleInfo type="abbreviated"><title>J Eur Acad Dermatol Venereol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Short Report</topic><topic>INFLAMMATORY SKIN DISEASES</topic></subject><identifier type="ISSN">0926-9959</identifier><identifier type="eISSN">1468-3083</identifier><identifier type="DOI">10.1111/(ISSN)1468-3083</identifier><identifier type="PublisherID">JDV</identifier><part><date>2016</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><detail type="issue"><caption>no.</caption><number>10</number></detail><extent unit="pages"><start>1799</start><end>1804</end><total>6</total></extent></part></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0001"><titleInfo><title>Sarcoidosis</title></titleInfo><name type="personal"><namePart type="given">KW</namePart><namePart type="family">Thomas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GW</namePart><namePart type="family">Hunninghake</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003; 289: 3300–3303.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>289</number></detail><extent unit="pages"><start>3300</start><end>3303</end></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>289</number></detail><extent unit="pages"><start>3300</start><end>3303</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0002"><titleInfo><title>Etiology of sarcoidosis</title></titleInfo><name type="personal"><namePart type="given">ES</namePart><namePart type="family">Chen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DR</namePart><namePart type="family">Moller</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med 2008; 29: 365–377.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>365</start><end>377</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Chest Med</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>365</start><end>377</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0003"><titleInfo><title>A practical approach to cutaneous sarcoidosis</title></titleInfo><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Wanat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rosenbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wanat KA, Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol 2014; 15: 283–297.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>283</start><end>297</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Clin Dermatol</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>283</start><end>297</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0004"><titleInfo><title>Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rosenbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Yeung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Chu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rosenbach M, Yeung H, Chu E et al. Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis. JAMA Dermatol 2013; 149: 550–556.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>149</number></detail><extent unit="pages"><start>550</start><end>556</end></extent></part><relatedItem type="host"><titleInfo><title>JAMA Dermatol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>149</number></detail><extent unit="pages"><start>550</start><end>556</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0005"><titleInfo><title>Cutaneous involvement in sarcoidosis: analysis features in 170 patients</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Yanardag</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ON</namePart><namePart type="family">Pamuk</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Karayel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis features in 170 patients. Resp Med 2003; 97: 978–982.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>97</number></detail><extent unit="pages"><start>978</start><end>982</end></extent></part><relatedItem type="host"><titleInfo><title>Resp Med</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>97</number></detail><extent unit="pages"><start>978</start><end>982</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0006"><titleInfo><title>Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore</title></titleInfo><name type="personal"><namePart type="given">WS</namePart><namePart type="family">Chong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HH</namePart><namePart type="family">Tan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Tan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chong WS, Tan HH, Tan SH. Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore. Clin Dermatol 2005; 30: 120–124.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>120</start><end>124</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Dermatol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>120</start><end>124</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0007"><titleInfo><title>Cutaneous sarcoidosis in black South Africans</title></titleInfo><name type="personal"><namePart type="given">WK</namePart><namePart type="family">Jacyk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jacyk WK. Cutaneous sarcoidosis in black South Africans. Int J Dermatol 1999; 38: 841–845.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>841</start><end>845</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>841</start><end>845</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0008"><titleInfo><title>Comparison of cutaneous sarcoidosis with systemic sarcoidosis: a retrospective analysis</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Tong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Dong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">He</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tong C, Zhang X, Dong J, He Y. Comparison of cutaneous sarcoidosis with systemic sarcoidosis: a retrospective analysis. Int J Clin Exp Pathol 2014; 7: 372–377.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>372</start><end>377</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Exp Pathol</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>372</start><end>377</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0009"><titleInfo><title>The epidemiology of sarcoidosis in Rochester Minnesota: a population‐based study of incidence and survival</title></titleInfo><name type="personal"><namePart type="given">CE</namePart><namePart type="family">Henke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Henke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LR</namePart><namePart type="family">Elveback</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CM</namePart><namePart type="family">Beard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Ballard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LT</namePart><namePart type="family">Kurland</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester Minnesota: a population‐based study of incidence and survival. Am J Epidemiol 1986; 123: 840–845.</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>123</number></detail><extent unit="pages"><start>840</start><end>845</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Epidemiol</title></titleInfo><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>123</number></detail><extent unit="pages"><start>840</start><end>845</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0010"><titleInfo><title>History of the Rochester Epidemiology Project: Half a century of medical records linkage in a U.S. population</title></titleInfo><name type="personal"><namePart type="given">WA</namePart><namePart type="family">Rocca</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BP</namePart><namePart type="family">Yawn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">St. Sauver</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BR</namePart><namePart type="family">Grossardt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LJ</namePart><namePart type="family">Melton III</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rocca WA, Yawn BP, St. Sauver JL, Grossardt BR, Melton LJ III. History of the Rochester Epidemiology Project: Half a century of medical records linkage in a U.S. population. Mayo Clin Proc 2012; 87: 1202–1213.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>1202</start><end>1213</end></extent></part><relatedItem type="host"><titleInfo><title>Mayo Clin Proc</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>1202</start><end>1213</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0011"><titleInfo><title>History of the Rochester epidemiology project</title></titleInfo><name type="personal"><namePart type="given">LJ</namePart><namePart type="family">Melton 3rd</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Melton LJ 3rd. History of the Rochester epidemiology project. Mayo Clin Proc 1996; 71: 266–274.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>71</number></detail><extent unit="pages"><start>266</start><end>274</end></extent></part><relatedItem type="host"><titleInfo><title>Mayo Clin Proc</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>71</number></detail><extent unit="pages"><start>266</start><end>274</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0012"><titleInfo><title>Cutaneous sarcoidosis</title></titleInfo><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Marchell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Judson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Resp Crit Care Med 2010; 31: 442–451.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>442</start><end>451</end></extent></part><relatedItem type="host"><titleInfo><title>Semin Resp Crit Care Med</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>442</start><end>451</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0013"><titleInfo><title>Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis</title></titleInfo><name type="personal"><namePart type="given">RP</namePart><namePart type="family">Baughman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Teirstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Judson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baughman RP, Teirstein AS, Judson MA et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885–1889.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>164</number></detail><extent unit="pages"><start>1885</start><end>1889</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Respir Crit Care Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>164</number></detail><extent unit="pages"><start>1885</start><end>1889</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="jdv13760-cit-0014"><titleInfo><title>Sarcoidosis in South Africa: a comparative study in whites, blacks and coloured</title></titleInfo><name type="personal"><namePart type="given">SR</namePart><namePart type="family">Benatar</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Benatar SR. Sarcoidosis in South Africa: a comparative study in whites, blacks and coloured. S Afr Med J 1977; 52: 602–606.</note><part><date>1977</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>602</start><end>606</end></extent></part><relatedItem type="host"><titleInfo><title>S Afr Med J</title></titleInfo><part><date>1977</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>602</start><end>606</end></extent></part></relatedItem></relatedItem><identifier type="istex">ACCC5804FFBF78BC8890F975DBF09145DD0EA6BF</identifier><identifier type="ark">ark:/67375/WNG-0LJ6ZCXM-M</identifier><identifier type="DOI">10.1111/jdv.13760</identifier><identifier type="ArticleID">JDV13760</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2016 European Academy of Dermatology and Venereology© 2016 European Academy of Dermatology and Venereology</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-0LJ6ZCXM-M/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:ACCC5804FFBF78BC8890F975DBF09145DD0EA6BF
|texte= Epidemiology of cutaneous sarcoidosis, 1976–2013: a population‐based study from Olmsted County, Minnesota
}}
| This area was generated with Dilib version V0.6.33. |  |